3.78

5.50% -0.22

Lunai Bioworks Inc (LNAI)

Overview News Price History Discussions Forecast

Lunai Bioworks Inc stock is traded at $3.78, with a volume of 1.02M. It is down -5.50% in the last 24 hours and up +82.79% over the past month. Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

Previous Close:

$4.00

Open:

$3.56

24h Volume:

1.02M

Relative Volume:

0.35

Market Cap:

$17.14M

Revenue:

Net Income/Loss:

$-128.28M

P/E Ratio:

-0.0617

EPS:

-61.2898

Net Cash Flow:

$-5.26M

1W Performance:

+51.20%

1M Performance:

+82.79%

6M Performance:

-54.13%

1Y Performance:

+0.00%

1-Day Range:

$3.50

$4.01

1-Week Range:

$2.40

$5.02

52-Week Range:

$1.2104

$13.28

Lunai Bioworks Inc Stock (LNAI) Company Profile

Name

Lunai Bioworks Inc

Sector

Healthcare (1104)

Industry

Biotechnology (617)

Phone

45 39179840

Address

CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES

Employee

Twitter

Next Earnings Date

2026-05-21

Latest SEC Filings

LNAI's Discussions on Twitter

Compare LNAI vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LNAI Lunai Bioworks Inc	3.78	17.14M	0	-128.28M	-5.26M	-61.29
VRTX Vertex Pharmaceuticals Inc	451.63	114.63B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	609.94	63.95B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.72	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	278.09	37.13B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	162.99	34.65B	742.00K	-1.37B	-1.07B	-7.0731

Lunai Bioworks Inc (LNAI)

Lunai Bioworks Inc Stock (LNAI) Company Profile

Compare LNAI vs VRTX, REGN, ARGX, ALNY, RVMD

Lunai Bioworks Inc Stock (LNAI) Latest News

Lunai Bioworks Pursues Legal Action Over Alleged Manipulation - TipRanks

Lunai Bioworks secures first revenue defense contract, files expedited discovery in naked shorting suit - TradingView

[8-K] Lunai Bioworks Inc. Reports Material Event - Stock Titan

Lunai Bioworks Ord Shs (LNAI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

LNAI Stock Explodes On Volume As Traders Target Volatility - StocksToTrade

Lunai Bioworks (LNAI) Stock Soars 81% Following Nasdaq Compliance Restoration - parameter.io

Lunai Bioworks (LNAI) Stock Soars 81% on Nasdaq Compliance Restoration - Blockonomi

Lunai Bioworks (LNAI) Stock Jumps 81% After Nasdaq Compliance News - CoinCentral

LNAI Stock Sees Volatile Spike As Traders Zero In On Risk - timothysykes.com

LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS - PR Newswire

Lunai Bioworks stock jumps after Nasdaq bid-price compliance filing - TechStock²

Morning Market Movers: EHGO, LNAI, SDOT, LILA See Big Swings - RTTNews

Why Did LNAI Stock Soar Over 100% In Pre-Market Trading Today? - Stocktwits

Trending Stocks Today | Lunai Bioworks Surges 151.66% Pre-Market - Moomoo

Why Did Lunai Bioworks Surge After Regaining Nasdaq Compliance? - Kalkine Media

Lunai Bioworks (LNAI) Stock Is Trending Overnight — Here's Why It Spiked Nearly 81% In After-Hours Session - Benzinga

Lunai Bioworks Ord Shs (LNAI) Institutional Confidence - TradingKey

Trending Stocks Today | Sadot Shoots up 73.01% Post-Market - Moomoo

Lunai Bioworks Regains Nasdaq Compliance, Enters Monitoring Period - TipRanks

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Lunai BioworksRegains Nasdaq Compliance With Minimum $1 Bid Price RuleSEC Filing - TradingView

Lunai regains Nasdaq $1.00 bid-price compliance; one-year Panel monitoring imposed - TradingView

Lunai Bioworks (NASDAQ: LNAI) back in bid compliance but under 1-year Nasdaq monitor - Stock Titan

LNAI Should I Buy - Intellectia AI

Why Is This Micro-Cap Biotech Stock Up 150% Today? - Stocktwits

Lunai Bioworks Inc Stock Short Interest Rises to 62.94% - Quiver Quantitative

Top Lunai Bioworks (LNAI) Competitors 2026 - MarketBeat

LNAI Q1 2026 Earnings: Pre-Revenue Biotech Reports EPS of -$0.08, Shares AdvanceEarnings Revision Downgrade - newsline.com

LNAI Stock Chart | LUNAI BIOWORKS INC (NASDAQ:LNAI) - ChartMill

LNAI Q1 2026 Earnings: EPS Loss in Line with Expectations as Biotech Advances Pipeline; Stock Surges 16%Slow Growth Warning - The Legal Advocate

Lunai Bioworks Inc. (LNAI) Q1 2026 Earnings: Early-Stage Biotech Posts Narrower-Than-Expected Loss, Shares Surge Over 16%Revenue Beat Analysis - The Legal Advocate

Lunai Bioworks partners with BrainStorm on neurology drug discovery - Investing.com UK

Lunai Bioworks and BrainStorm launch foundation for neurological diseases - TipRanks

Lunai Bioworks Inc. and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's And Rare Epilepsy AI Discovery Collaboration - marketscreener.com

Lunai Bioworks partners with BrainStorm on neurology drug discovery By Investing.com - Investing.com Australia

AI and human brain organoids join forces on Parkinson's, rare epilepsy - Stock Titan

Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration - PR Newswire

Lunai Bioworks, Inc. Cash Flow – LS:A42CL6 - TradingView

Pretax income of Lunai Bioworks, Inc. – LS:A42CL6 - TradingView

Lunai Bioworks Company Profile & Introduction - Moomoo

Lunai Bioworks, Inc. Financial Disclosures & SEC Filings - TradingView

Lunai Bioworks Heads Into Key Week After Reverse Split, Ongoing Court Battle - Bez Kabli

Lunai Bioworks to implement 1-for-8 reverse stock split - MSN

Lunai Bioworks Inc. (LNAI) Q1 2026 Earnings: Pre-Revenue Biotech Reports Wider-Than-Expected Loss Amid Pipeline ProgressEnergy Earnings Report - Newser

Federal Judge Orders Expedited Discovery to Identify 'John Doe' Defendants 'Naked' Short-Sellers of Lunai Common Stock - Quantisnow

Lunai Bioworks federal judge grants Lunai Bioworks expedited discovery to identify "naked" short sellers - marketscreener.com

Lunai Bioworks Federal Judge Grants Lunai Bioworks Expedited Discovery To Identify "Naked" Short Sellers - TradingView

Lunai Bioworks Inc. (LNAI) Q1 2026 Earnings: Early-Stage Biotech Delivers Strategic Progress Despite GAAP LossFinancial Summary - The Legal Advocate

Lunai Bioworks (LNAI) Q1 2026 Earnings: As Expected, No SurprisesEarnings Volatility Report - Newser

Lunai Bioworks Announces 1-for-8 Reverse Stock Split - The Globe and Mail

Lunai Bioworks Announces 1-for-8 Reverse Stock Split to Regain Nasdaq Compliance - Minichart

Lunai Bioworks Inc Stock (LNAI) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to LNAI